Wed. 27 Mar 2024, 7:38am ET
Benzinga
Earnings, News
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.44) by 20.45 percent. This is a 47.76 percent increase over losses of $(0.67) per share from the same period last year.